Spyre Therapeutics (SYRE) Treasury Shares (2015 - 2025)
Spyre Therapeutics (SYRE) posted Treasury Shares of $76932.0 for Q4 2025, down 33.33% on a QoQ basis from $115398.0 in Q4 2024, and down 33.33% year-over-year from $115398.0 in Q4 2024.
Spyre Therapeutics (SYRE) Treasury Shares (2015 - 2025) Analysis & Trends
Spyre Therapeutics' Treasury Shares history runs 8 years deep, the most recent figure standing at $76932.0 for Q4 2025.
- Quarterly Treasury Shares fell 33.33% year-over-year to $76932.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76932.0 (down 33.33% YoY) and the FY2025 annual result came in at $76932.0, down 33.33% from the prior year.
- Treasury Shares was $76932.0 for Q4 2025 at Spyre Therapeutics, down from $115398.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.1 million in Q3 2023 and bottomed at $76932.0 in Q4 2025.
- A 4-year average of $326981.1 and a median of $181500.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares jumped 624.0% — and 2025, when it plunged 33.33%.
- Spyre Therapeutics' Treasury Shares stood at $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then decreased by 23.07% to $115398.0 in 2024, then slumped by 33.33% to $76932.0 in 2025.
- Business Quant data shows SYRE's Treasury Shares at $76932.0 in Q4 2025, $115398.0 in Q4 2024, and $272000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76,932.00 |
| Dec 31, 2025 | 76,932.00 |
| Dec 31, 2024 | 115,398.00 |
| Dec 31, 2024 | 115,398.00 |
| Mar 31, 2024 | 272,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 721,000.00 |
| Jun 30, 2023 | 721,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 181,500.00 |
| Jun 30, 2022 | 181,500.00 |
| Mar 31, 2022 | 190,000.00 |
| Mar 31, 2022 | 190,000.00 |
| Dec 31, 2018 | 6,863.00 |
| Dec 31, 2018 | 6,863.00 |